Nitric Oxide Inhibits the Tumor Necrosis Factor α-regulated Endocytosis of Human Dendritic Cells in a Cyclic GMP-dependent Way
Open Access
- 1 June 2000
- journal article
- Published by Elsevier
- Vol. 275 (26) , 19638-19644
- https://doi.org/10.1074/jbc.m000511200
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophagesEuropean Journal of Immunology, 1998
- NADPH diaphorase‐positive dendritic profiles in rat thymus are discrete from autofluorescent cells, immunoreactive for inducible nitric oxide synthase, and show strain‐specific abundance differencesImmunology, 1998
- NITRIC OXIDE AND MACROPHAGE FUNCTIONAnnual Review of Immunology, 1997
- Ceramide Inhibits Antigen Uptake and Presentation by Dendritic CellsThe Journal of Experimental Medicine, 1996
- Nitric Oxide: Pathophysiological MechanismsAnnual Review of Physiology, 1995
- Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.The Journal of Experimental Medicine, 1995
- Altered immune responses in mice lacking inducible nitric oxide synthaseNature, 1995
- Regulation of lymphocyte functions by nitric oxideCurrent Opinion in Immunology, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages.The Journal of Experimental Medicine, 1993